Principals: Paul Gallagher
Paul Gallagher, MBA
Paul has over 35 years in healthcare that is characterized by its breadth and extensive experience in the development and commercialization of innovations.
Before founding Compass in 1994, Paul worked for legacy companies of Novartis (Ciba-Geigy), Sanofi (Merrell Dow) and Pfizer (Wyeth), holding positions of increasing responsibilities in marketing research, product management, sales management and executive commercial management, including Vice President of Global Marketing.
Compass specializes in global market access intelligence and strategies. Compass provides pricing, value, and access assessments and strategies in the pharma, biotech, and diagnostic sectors.
Paul holds a BA in economics from Columbia University and an MBA in marketing from George Washington University.
He has been a member of the Faculty of the Drug Development Boot Camp at Harvard University from 2010 through 2015, moderated a panel on Commercialization and Reimbursement of Gene Therapies at the Genetic Rx Conference, and been a Panelist on What’s Hot & What’s Not in Gene Therapies for Rare Disorders, Webinar sponsored by BIO.
In October 2015, he proposed and then moderated an industry-payer panel on Addressing Payer’s Heightened Aggressiveness in Managing Price and Access in Forecasting, Valuations, and Deal Terms at the Licensing Executives Society annual meeting.